Kazia Therapeutics (KZIA) Cash from Discontinued Operations (2012 - 2013)

Kazia Therapeutics' (KZIA) quarterly Cash from Discontinued Operations came in at 3879012.47 in Q4 2013, down 135.71% YoY from 10861695.39 in Q4 2012, and down 135.71% on a QoQ basis from 10861695.39 in Q4 2012.

Kazia Therapeutics (KZIA) Cash from Discontinued Operations (2012 - 2013) Analysis & Trends

Kazia Therapeutics (KZIA) has 2 years of Cash from Discontinued Operations data on file, last reported at 3879012.47 in Q4 2013.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Discontinued Operations (Qtr)
1 Vertex Pharmaceuticals 128.13 Bn 120.28 Bn 2.84 Bn -
2 Regeneron Pharmaceuticals 112.33 Bn 104.33 Bn 3.93 Bn -
3 Argenx Se 53.24 Bn 48.05 Bn 1.41 Bn -
4 Revolution Medicines 43.64 Bn 43.64 Bn - -
5 BeOne Medicines 39.27 Bn 34.17 Bn 1.53 Bn -
6 MindWalk Holdings 35.32 Bn 35.31 Bn 1.82 Bn 7.90 Mn
7 Royalty Pharma 33.72 Bn 35.84 Bn - -
8 Alnylam Pharmaceuticals 30.58 Bn 27.27 Bn 992.69 Mn -
9 Insmed 27.01 Bn 25.85 Bn 358.27 Mn -
10 Kazia Therapeutics 4.22 Bn 4.22 Bn - -

Historic Data

Download Data
DateValue
Dec 31, 2013 -3.88 Mn
Dec 31, 2013 -3.88 Mn
Dec 31, 2012 10.86 Mn
Dec 31, 2012 10.86 Mn